Literature DB >> 27496617

Off-pump versus on-pump coronary artery bypass surgery in patients with actively treated diabetes and multivessel coronary disease.

Umberto Benedetto1, Massimo Caputo2, Hunaid Vohra2, Alan Davies2, James Hillier2, Alan Bryan2, Gianni D Angelini2.   

Abstract

OBJECTIVES: We conducted a single-center analysis on short-term outcomes and long-term survival in actively treated diabetic patients undergoing off-pump coronary artery bypass versus on-pump coronary artery bypass surgery.
METHODS: The final population consisted of 2450 patients with actively treated diabetes (mean age, 66 ± 9 years; female/male 545/1905, 22%). Of those, 1493 subjects were orally treated and 1011 subjects were taking insulin. Off-pump coronary artery bypass and on-pump coronary artery bypass were performed in 1253 and 1197 patients, respectively. Propensity score matching was used to compare the 2 matched groups.
RESULTS: When compared with on-pump coronary artery bypass, off-pump coronary artery bypass was associated with a significant risk reduction for postoperative cerebrovascular accident (odds ratio, 0.49; 95% confidence interval [CI], 0.25-0.99; P = .04), need for postoperative intra-aortic balloon pump (odds ratio, 0.48; 95% CI, 0.30-0.77; P = .002), and reexploration for bleeding (odds ratio, 0.55; 95% CI, 0.33-0.94; P = .02). Off-pump coronary artery bypass did not significantly affect early (hazard ratio [HR], 1.32; 95% CI, 0.73-2.40; P = .36) and late (HR, 1.08; 95% CI, 0.92-1.28; P = .32) mortality. However, off-pump coronary artery bypass with incomplete revascularization was associated with reduced survival when compared with off-pump coronary artery bypass with complete revascularization (HR, 1.82; 95% CI, 1.34-2.46; P = .0002) and on-pump coronary artery bypass with complete revascularization (HR, 1.83; 95% CI, 1.36-2.47; P < .0001).
CONCLUSIONS: Off-pump coronary artery bypass is a safe and feasible option for diabetic patients with multivessel disease, reduces the incidence of early complications including postoperative cerebrovascular events, and provides excellent long-term survival similar to on-pump coronary artery bypass surgery in case of complete revascularization. Crown
Copyright © 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  diabetes mellitus; off-pump coronary artery bypass grafting; survival

Mesh:

Year:  2016        PMID: 27496617     DOI: 10.1016/j.jtcvs.2016.06.038

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

Review 1.  Impact of off-pump coronary artery bypass grafting on survival: current best available evidence.

Authors:  Pierpaolo Chivasso; Gustavo A Guida; Daniel Fudulu; Vito D Bruno; Roberto Marsico; Hristo Sedmakov; Mustafa Zakkar; Filippo Rapetto; Alan J Bryan; Gianni D Angelini
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 2.  Current outcomes of off-pump coronary artery bypass grafting: evidence from real world practice.

Authors:  Piroze M Davierwala
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Failure of Isoflurane Cardiac Preconditioning in Obese Type 2 Diabetic Mice Involves Aberrant Regulation of MicroRNA-21, Endothelial Nitric-oxide Synthase, and Mitochondrial Complex I.

Authors:  Zhi-Dong Ge; Yingchuan Li; Shigang Qiao; Xiaowen Bai; David C Warltier; Judy R Kersten; Zeljko J Bosnjak; Mingyu Liang
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

Review 4.  Off-Pump Coronary Artery Bypass Grafting; is it Still Relevant?

Authors:  Chima K P Ofoegbu; Rodgers M Manganyi
Journal:  Curr Cardiol Rev       Date:  2022

5.  Impact of diabetes mellitus on coagulation function before and after off-pump coronary artery bypass grafting.

Authors:  Dawei Wang; Yu Liu; Ziying Chen; Fei Yang; Zhenming Zhang; Yulei Wei
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

Review 6.  The application of remote ischemic conditioning in cardiac surgery.

Authors:  Zeljko J Bosnjak; Zhi-Dong Ge
Journal:  F1000Res       Date:  2017-06-16

7.  Inactivation of TOPK Caused by Hyperglycemia Blocks Diabetic Heart Sensitivity to Sevoflurane Postconditioning by Impairing the PTEN/PI3K/Akt Signaling.

Authors:  Sumin Gao; Rong Wang; Siwei Dong; Jing Wu; Bartłomiej Perek; Zhengyuan Xia; Shanglong Yao; Tingting Wang
Journal:  Oxid Med Cell Longev       Date:  2021-04-23       Impact factor: 6.543

Review 8.  Revascularization strategies for patients with established chronic coronary syndrome.

Authors:  Casper F Coerkamp; Marieke Hoogewerf; Bart P van Putte; Yolande Appelman; Pieter A Doevendans
Journal:  Eur J Clin Invest       Date:  2022-04-29       Impact factor: 5.722

Review 9.  Adjuvant Therapy With Mushroom Polysaccharides for Diabetic Complications.

Authors:  Xue Jiang; Weiqi Meng; Lanzhou Li; Zhaoli Meng; Di Wang
Journal:  Front Pharmacol       Date:  2020-02-28       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.